289 related articles for article (PubMed ID: 31959971)
1. Growth effects of N-acylethanolamines on gut bacteria reflect altered bacterial abundances in inflammatory bowel disease.
Fornelos N; Franzosa EA; Bishai J; Annand JW; Oka A; Lloyd-Price J; Arthur TD; Garner A; Avila-Pacheco J; Haiser HJ; Tolonen AC; Porter JA; Clish CB; Sartor RB; Huttenhower C; Vlamakis H; Xavier RJ
Nat Microbiol; 2020 Mar; 5(3):486-497. PubMed ID: 31959971
[TBL] [Abstract][Full Text] [Related]
2. Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
Robinson AM; Gondalia SV; Karpe AV; Eri R; Beale DJ; Morrison PD; Palombo EA; Nurgali K
Inflamm Bowel Dis; 2016 Dec; 22(12):2767-2787. PubMed ID: 27824648
[TBL] [Abstract][Full Text] [Related]
3. [Gut microbiota and IBD].
Seksik P
Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 1():S44-51. PubMed ID: 20889004
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiome structure and metabolic activity in inflammatory bowel disease.
Franzosa EA; Sirota-Madi A; Avila-Pacheco J; Fornelos N; Haiser HJ; Reinker S; Vatanen T; Hall AB; Mallick H; McIver LJ; Sauk JS; Wilson RG; Stevens BW; Scott JM; Pierce K; Deik AA; Bullock K; Imhann F; Porter JA; Zhernakova A; Fu J; Weersma RK; Wijmenga C; Clish CB; Vlamakis H; Huttenhower C; Xavier RJ
Nat Microbiol; 2019 Feb; 4(2):293-305. PubMed ID: 30531976
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome.
Vich Vila A; Imhann F; Collij V; Jankipersadsing SA; Gurry T; Mujagic Z; Kurilshikov A; Bonder MJ; Jiang X; Tigchelaar EF; Dekens J; Peters V; Voskuil MD; Visschedijk MC; van Dullemen HM; Keszthelyi D; Swertz MA; Franke L; Alberts R; Festen EAM; Dijkstra G; Masclee AAM; Hofker MH; Xavier RJ; Alm EJ; Fu J; Wijmenga C; Jonkers DMAE; Zhernakova A; Weersma RK
Sci Transl Med; 2018 Dec; 10(472):. PubMed ID: 30567928
[TBL] [Abstract][Full Text] [Related]
6. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
7. Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease.
Chehoud C; Albenberg LG; Judge C; Hoffmann C; Grunberg S; Bittinger K; Baldassano RN; Lewis JD; Bushman FD; Wu GD
Inflamm Bowel Dis; 2015 Aug; 21(8):1948-56. PubMed ID: 26083617
[TBL] [Abstract][Full Text] [Related]
8. Functional dynamics of bacterial species in the mouse gut microbiome revealed by metagenomic and metatranscriptomic analyses.
Chung YW; Gwak HJ; Moon S; Rho M; Ryu JH
PLoS One; 2020; 15(1):e0227886. PubMed ID: 31978162
[TBL] [Abstract][Full Text] [Related]
9. Dynamics of metatranscription in the inflammatory bowel disease gut microbiome.
Schirmer M; Franzosa EA; Lloyd-Price J; McIver LJ; Schwager R; Poon TW; Ananthakrishnan AN; Andrews E; Barron G; Lake K; Prasad M; Sauk J; Stevens B; Wilson RG; Braun J; Denson LA; Kugathasan S; McGovern DPB; Vlamakis H; Xavier RJ; Huttenhower C
Nat Microbiol; 2018 Mar; 3(3):337-346. PubMed ID: 29311644
[TBL] [Abstract][Full Text] [Related]
10. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
[TBL] [Abstract][Full Text] [Related]
11. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
Huh JW; Roh TY
BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic and prognostic potential of gut bacteria in inflammatory bowel disease.
Wiredu Ocansey DK; Hang S; Yuan X; Qian H; Zhou M; Valerie Olovo C; Zhang X; Mao F
Gut Microbes; 2023; 15(1):2176118. PubMed ID: 36794838
[TBL] [Abstract][Full Text] [Related]
13. Ursodeoxycholic Acid and Its Taurine- or Glycine-Conjugated Species Reduce Colitogenic Dysbiosis and Equally Suppress Experimental Colitis in Mice.
Van den Bossche L; Hindryckx P; Devisscher L; Devriese S; Van Welden S; Holvoet T; Vilchez-Vargas R; Vital M; Pieper DH; Vanden Bussche J; Vanhaecke L; Van de Wiele T; De Vos M; Laukens D
Appl Environ Microbiol; 2017 Apr; 83(7):. PubMed ID: 28115375
[TBL] [Abstract][Full Text] [Related]
14. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.
Weng YJ; Gan HY; Li X; Huang Y; Li ZC; Deng HM; Chen SZ; Zhou Y; Wang LS; Han YP; Tan YF; Song YJ; Du ZM; Liu YY; Wang Y; Qin N; Bai Y; Yang RF; Bi YJ; Zhi FC
J Dig Dis; 2019 Sep; 20(9):447-459. PubMed ID: 31240835
[TBL] [Abstract][Full Text] [Related]
15. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
16. Ginsenoside CK Alleviates DSS-Induced IBD in Mice by Regulating Tryptophan Metabolism and Activating Aryl Hydrocarbon Receptor via Gut Microbiota Modulation.
Liu Y; Bai X; Wu H; Duan Z; Zhu C; Fu R; Fan D
J Agric Food Chem; 2024 May; 72(17):9867-9879. PubMed ID: 38602268
[TBL] [Abstract][Full Text] [Related]
17. Metagenomic Alterations in Gut Microbiota Precede and Predict Onset of Colitis in the IL10 Gene-Deficient Murine Model.
Miyoshi J; Lee STM; Kennedy M; Puertolas M; Frith M; Koval JC; Miyoshi S; Antonopoulos DA; Leone V; Chang EB
Cell Mol Gastroenterol Hepatol; 2021; 11(2):491-502. PubMed ID: 32835897
[TBL] [Abstract][Full Text] [Related]
18. Effect of cinnamon essential oil on gut microbiota in the mouse model of dextran sodium sulfate-induced colitis.
Li AL; Ni WW; Zhang QM; Li Y; Zhang X; Wu HY; Du P; Hou JC; Zhang Y
Microbiol Immunol; 2020 Jan; 64(1):23-32. PubMed ID: 31595527
[TBL] [Abstract][Full Text] [Related]
19. Quantitative Metaproteomics and Activity-Based Probe Enrichment Reveals Significant Alterations in Protein Expression from a Mouse Model of Inflammatory Bowel Disease.
Mayers MD; Moon C; Stupp GS; Su AI; Wolan DW
J Proteome Res; 2017 Feb; 16(2):1014-1026. PubMed ID: 28052195
[TBL] [Abstract][Full Text] [Related]
20. Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.
Duboc H; Rajca S; Rainteau D; Benarous D; Maubert MA; Quervain E; Thomas G; Barbu V; Humbert L; Despras G; Bridonneau C; Dumetz F; Grill JP; Masliah J; Beaugerie L; Cosnes J; Chazouillères O; Poupon R; Wolf C; Mallet JM; Langella P; Trugnan G; Sokol H; Seksik P
Gut; 2013 Apr; 62(4):531-9. PubMed ID: 22993202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]